These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16504822)

  • 1. Newer therapeutic approaches: spondyloarthritis and uveitis.
    Ritchlin C
    Rheum Dis Clin North Am; 2006 Feb; 32(1):75-90, viii. PubMed ID: 16504822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of spondyloarthritis.
    Braun J; Sieper J
    Nat Clin Pract Rheumatol; 2006 Oct; 2(10):536-45. PubMed ID: 17016479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory arthritides of the spine: surgical versus nonsurgical treatment.
    Borenstein D
    Clin Orthop Relat Res; 2006 Feb; 443():208-21. PubMed ID: 16462444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular involvement in spondylarthritis--new mechanisms, new therapies].
    Itulescu TC; Alexandrescu C; Voinea LM
    Oftalmologia; 2014; 58(1):27-35. PubMed ID: 25145120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radon therapy in medical rehabilitation of patients with seronegative spondyloarthritis. An open controlled study].
    Barnatskiĭ VV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (4):11-4. PubMed ID: 18819362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of biologic agents in the therapy of ankylosing spondylitis].
    Géher P; Nagy MB; Péntek M; Tóth E; Brodszky V; Gulácsi L
    Orv Hetil; 2006 Jul; 147(26):1203-13. PubMed ID: 16898082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spondyloarthritis: from unifying concepts to improved treatment.
    Paramarta JE; Baeten D
    Rheumatology (Oxford); 2014 Sep; 53(9):1547-59. PubMed ID: 24369419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spondyloarthritis.
    Dougados M; Baeten D
    Lancet; 2011 Jun; 377(9783):2127-37. PubMed ID: 21684383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the spondyloarthritides in patients with uveitis.
    Linder R; Hoffmann A; Brunner R
    J Rheumatol; 2004 Nov; 31(11):2226-9. PubMed ID: 15517636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of stem cells in spondyloarthritis: Pathogenesis, treatment and complications.
    Wong RS
    Hum Immunol; 2015 Oct; 76(10):781-8. PubMed ID: 26429327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations.
    Rohekar S; Chan J; Tse SM; Haroon N; Chandran V; Bessette L; Mosher D; Flanagan C; Keen KJ; Adams K; Mallinson M; Thorne C; Rahman P; Gladman DD; Inman RD
    J Rheumatol; 2015 Apr; 42(4):665-81. PubMed ID: 25684768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal transplants in spondyloarthritis and uveitis: ready for a clinical trial?
    Choi RY; Asquith M; Rosenbaum JT
    Curr Opin Rheumatol; 2018 Jul; 30(4):303-309. PubMed ID: 29538010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of spondyloarthritis in 504 Chinese patients with HLA-B27-associated acute anterior uveitis.
    Chung YM; Liao HT; Lin KC; Lin YC; Chou CT; Chen CH; Tsai CP
    Scand J Rheumatol; 2009; 38(2):84-90. PubMed ID: 18821178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in Canada.
    Rohekar S; Chan J; Tse SM; Haroon N; Chandran V; Bessette L; Mosher D; Flanagan C; Keen KJ; Adams K; Mallinson M; Thorne C; Rahman P; Gladman DD; Inman RD
    J Rheumatol; 2015 Apr; 42(4):654-64. PubMed ID: 25684770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues related to clinical trials of oral and biologic disease-modifying agents for Sjögren's syndrome.
    Carsons SE
    Rheum Dis Clin North Am; 2008 Nov; 34(4):1011-23, x. PubMed ID: 18984419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in therapy of spondylarthritis].
    Mau W; Meran JG; Langer HE
    Wien Med Wochenschr; 1990 Jun; 140(12):338-42. PubMed ID: 2204219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapy for seronegative arthritides (spondyloarthritis).
    Dougados M
    Bull NYU Hosp Jt Dis; 2011; 69(3):250-2. PubMed ID: 22035438
    [No Abstract]   [Full Text] [Related]  

  • 18. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis.
    Zochling J; Brandt J; Braun J
    Rheumatology (Oxford); 2005 Dec; 44(12):1483-91. PubMed ID: 16091395
    [No Abstract]   [Full Text] [Related]  

  • 19. Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
    Bansard C; Lequerré T; Daveau M; Boyer O; Tron F; Salier JP; Vittecoq O; Le-Loët X
    Rheumatology (Oxford); 2009 Sep; 48(9):1021-8. PubMed ID: 19483089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current controversies in spondyloarthritis: SPARTAN.
    Weisman M; Learch TJ; Baraliakos X; Chandran V; Gladman DD; Raychaudhuri SP; Xu H; Collantes-Estévez E; Vázquez-Mellado J; Mease PJ; Sieper J; Deodhar AA; Colbert RA; Clegg DO;
    J Rheumatol; 2010 Dec; 37(12):2617-23. PubMed ID: 21123334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.